As of March six, 2026, no official FDA reclassification continues to be published. But when it happens, the irony could well be amazing: the gray market’s most important vendor shuts down months before the compounds he spent years marketing turn into legally available via pharmacies.There is currently no verified rationalization. Regulatory… Read More